Clinical Trial: A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07184944) titled 'A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease' on Sept. 15.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled, maintenance, Phase 3 study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease (CD). Study details include:

The study duration may be up to 286 weeks including:

* 40-week Pivotal Maintenance Sub-Study

* 240-week Open-Label Extension (OLE) Sub-Study

* 45-day Follow-Up visit

Note: For the participants who do not enroll into OLE Sub-S...